He, L. SGLT2 Inhibitor And GLP-1 Receptor Agonist in Type 2 Diabetes Mellitus Patients. Research on Their Cardiovascular Benefits. HSET 2023, 74, 1717-1722. https://doi.org/10.54097/m9vm2798.